As the complexity of cancer screenings increases, community programs are seeking a more coordinated care experience for their patients. To achieve this goal, programs are improving staff efficiencies, investing in diagnostic skills development, and clarifying team member’s roles, among other initiatives.
To assist in these efforts, ACCC has created educational resources designed to help programs better align electronic health record (EHR) system workstreams with teams’ workflows. These resources will address reporting challenges within EHR systems and provide practical strategies that programs can use when placing reports into these systems.
Guided by advisory committees, ACCC will review community cancer program protocols regarding timely patient referrals so best practices can be identified and shared. Meetings with participating programs will be held to discuss quality improvement initiatives at their sites.
Lung cancer patients in underserved communities continue to have limited access to biomarker testing and precision medicine therapies. In partnership with LUNGevity, ACCC is seeking to eliminate these disparities so more patients can receive these life-saving tests and therapies.
Genetic testing is an essential tool for screening for cancer, but it is not accessible to everyone who could benefit from it. The Iowa Oncology Society has launched a program to help eliminate the barriers to genetic testing, counseling, and screening that many patients in the state face.
In response to cancer care disparities across underserved populations, some oncology practices have designated a "precision medicine steward" to serve as a point person for identifying and removing any roadblocks that limit patient access to guideline-concordant testing.